AJJ Medtech (SGX:584
) announces that it has won a four-year supply contract valued at approximately $3 million with a network of Singapore healthcare institutions.
The contract, which will commence on June 1, 2026, has a tenure of two years with an option to extend for a further two years, and covers the supply of biodegradable medical consumables.
With this latest win, AJJ Medtech’s total contracted institutional revenue pipeline now exceeds $8 million, which will be recognised over the next three to five years.
AJJ Medtech mentions that the latest contract win on biodegradable medical consumables will help support healthcare institutions’ efforts to adopt more environmentally responsible procurement practices.
“By enabling our healthcare partners to switch from conventional plastics to biodegradable alternatives, we deliver a clear, measurable environmental benefit that directly supports Singapore's climate objectives,” says Mr William Ong, CEO of AJJ Healthcare.
“Securing this long-term institutional contract reflects our continued execution in competitive healthcare tenders and strengthens the foundation of secured, recurring revenue for the Group,” says Alice Zhao, CEO of AJJ Medtech.
See also: Addvalue wins additional orders worth US$3.7 mil; order book reaches US$26.4 mil
AJJ Medtech points out that this latest contract win is not expected have a material impact on net tangible assets or earnings per share for the current financial year.
As of 9.15am, shares in AJJ Medtech are flat at 0.7 cents.
